News

May 13, 2019

Terapie avanzate, così l’Italia si candida al ruolo di hub internazionale

L’Italia come Hub internazionale per le terapie avanzate. Uno scenario di sfide e opportunitá

https://anemocyte.com/wp-content/uploads/2023/09/TerapieAvanzate-prev.jpg 512 288 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2023/09/TerapieAvanzate-prev.jpg May 13, 2019 March 26, 2025

A Smarter Way to Cap mRNA

Visual Inspection by Anemocyte

Off the Shelf mRNA, pDNA and IVT Kit solutions

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | Anemocyte Inc. 1221 Brickell Avenue, Suite 1160 Miami FL 33131

VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961